Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First results described for novel aromatase inhibitor in phase I

Feb. 6, 1998

Ilex initiates phase I testing of intoplicine

Feb. 6, 1998

DEHOP enters phase I for NHL

Feb. 6, 1998

Preclinical studies support potential of CP-358774 as cancer treatment

Feb. 4, 1998

Newly identified human natural killer cell-activating factor reported by HGS

Feb. 3, 1998

Pharmacological profile of new alkylating agent from Menarini

Feb. 3, 1998

Structure of new IL-6 inhibitors determined at Kitasato Institute

Feb. 2, 1998

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Phase I/II trial results reported for Neovastat in lung cancer

Jan. 30, 1998

Hybridon antitumor antisense compound enters clinical trials

Jan. 29, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...